Overview
OPK market data
Price History
OPK price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$0.30 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.50 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -23.9% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.98 – $1.73 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $1B · P/B 0.76 · P/S 1.35.
Company News
8-K filing — OPKO HEALTH, INC. (OPK)SEC EDGAR · Aug 14, 2026, 8:27 PM
OPKO Health Issues Additional $125M Of Senior Secured Notes To KKR's HealthCare Royalty For Non-Dilutive FundingBenzinga · Aug 13, 2026, 1:20 PM
Cocrystal Pharma Secures $5M Investment From OPKO Health To Advance Norovirus Program Toward Phase 1b DataBenzinga · Aug 3, 2026, 11:01 AM
12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga · Jul 28, 2026, 5:06 PM
Crude Oil Down Over 5%; Boeing Shares Rise After Q2 ResultsBenzinga · Jul 28, 2026, 4:28 PM
Sherwin-Williams Posts Upbeat Q2 Earnings, Joins Itron, Armstrong World And Other Big Stocks Moving Higher On TuesdayBenzinga · Jul 28, 2026, 2:05 PM
Opko Health shares are trading higher after the company reported better-than-expected Q2 sales results.Benzinga · Jul 28, 2026, 1:56 PM
Why Celestica Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving PremarketBenzinga · Jul 28, 2026, 9:01 AM
OPKO Health Raises FY2026 Sales Guidance from $530.000M-$560.000M to $560.000M-$585.000M vs $534.899M EstBenzinga · Jul 27, 2026, 8:07 PM
OPKO Health Sees Q3 Sales $131.000M-$142.000M vs $134.650M EstBenzinga · Jul 27, 2026, 8:07 PM